Setting the Stage of Real-World Data vs RCT
Renato D. Lopes, MD, MHS, PhD
Implementing the SOC Induction Therapies in AAV
Silke R. Brix, MD, MRCP, SCPR
Bernhard Hellmich, MD
Decoding ANCA-Associated Vasculitis (AAV): From Suspicion to Solution
Andreas Kronbichler, MD
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations
Valeria Caso, MD, PhD
Tailoring Treatment for Optimal Outcomes in Patients With AAV
Managing Patients With AAV in the Rheumatology Clinic
Patient Case Study: Cancer-Associated Thrombosis
Alexander T. Cohen, MD, MBBS
No Patient Left Behind! Advancing CKD-Associated Pruritus Care
Kieran McCafferty, MD
Maurizio Gallieni, MD
AHA 2024 and Acoramidis: Impact on the Future of ATTR-CM Patient Care
Mazen Hanna, MD
LDL-C Management Trends in ASCVD Patients
Keith C. Ferdinand, MD, FACC, FAHA , FASPC, FNLA, FPCNA
No benefit of routine spironolactone post-MI
Sanjit Jolly, MD
Semaglutide reduces MACE in patients with obesity or overweight and prior CABG
Subodh Verma, MD, PhD
Promising results with oral Lp(a) inhibitor in phase 2 trial
Stephen Nicholls, FRACP, FACC, FESC, FAHA
Tirzepatide reduces HF events in patients with HFpEF and obesity
Milton Packer, MD
Edoxaban as alternative to warfarin after bioprosthetic valve surgery
Chisato Izumi, MD, PhD
Acoramidis reduces all-cause mortality in ATTR-CM
Daniel Judge, MD
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.